Nuzhath Tasmiah, Yang Yingwei, Couture Marie-Claude, Gu Ning Yan, Comeau Jeannette L, Regan Annette K
Department of Health Science, University of Alabama, Tuscaloosa, USA; Global Health and Population, Harvard T. H. Chan School of Public Health, MA, USA.
Department of Health Science, University of Alabama, Tuscaloosa, USA.
Vaccine. 2025 Jan 25;45:126568. doi: 10.1016/j.vaccine.2024.126568. Epub 2024 Dec 19.
Acceptance of recommended vaccines is lower among pregnant people compared to non-pregnant adults, yet no tool has specifically measured prenatal vaccine hesitancy. We evaluated the performance of an existing adult Vaccine Hesitancy Scale (aVHS) in measuring vaccine hesitancy toward routinely recommended prenatal vaccines.
Between December 2021 and April 2022, we conducted a cross-sectional national online survey with 917 US postpartum adults 18-49 years old who had given birth in the past six months. Vaccine hesitancy was measured using the aVHS, a 10-item scale previously validated among the adult general population. Scores range from 10 to 50, with higher scores indicating greater vaccine hesitancy. Structural equation modeling (SEM) with weighted least squares means and variances adjusted (WLSMV) estimator was used to assess the fit of the aVHS structure. Construct validity was assessed by examining the correlation between the aVHS score and the self-reported receipt of recommended prenatal vaccines.
SEM indicated acceptable fit (RMSEA: 0.098; CFI: 0.983; TLI: 0.978; SRMR: 0.040) of the data to the two-factor model: (1) lack of vaccine confidence, and (2) perceived vaccine risks. For the paths from the two factors to the vaccine acceptance, lack of vaccine confidence was significantly correlated with influenza vaccine acceptance (β = -0.41, p < 0.001) and COVID-19 vaccine acceptance (β = -0.64, p < 0.001), while perceived vaccine risk was significantly linked with Tdap vaccine acceptance (β = -0.57, p < 0.001) and influenza vaccine acceptance (β = -0.25, p < 0.001). Additionally, pregnant people with higher aVHS scores were less likely to receive recommended prenatal vaccines.
Although the aVHS offered acceptable measurement of prenatal vaccine hesitancy, a scale that measures pregnancy-specific concerns may offer more tailored measurement for this unique population.
与非孕期成年人相比,孕妇对推荐疫苗的接受度较低,但尚无专门用于衡量产前疫苗犹豫程度的工具。我们评估了现有的成人疫苗犹豫量表(aVHS)在衡量对常规推荐的产前疫苗的犹豫程度方面的表现。
在2021年12月至2022年4月期间,我们对917名年龄在18至49岁、在过去六个月内分娩的美国产后成年人进行了一项全国性在线横断面调查。使用aVHS衡量疫苗犹豫程度,这是一个在成年普通人群中先前已验证的10项量表。分数范围为10至50分,分数越高表明疫苗犹豫程度越高。使用加权最小二乘均值和方差调整(WLSMV)估计器的结构方程模型(SEM)来评估aVHS结构的拟合度。通过检查aVHS分数与自我报告的推荐产前疫苗接种情况之间的相关性来评估结构效度。
SEM表明数据与双因素模型的拟合度可接受(RMSEA:0.098;CFI:0.983;TLI:0.978;SRMR:0.040):(1)缺乏疫苗信心,以及(2)感知到的疫苗风险。对于从这两个因素到疫苗接受度的路径,缺乏疫苗信心与流感疫苗接受度显著相关(β = -0.41,p < 0.001)和新冠疫苗接受度(β = -0.64,p < 0.001),而感知到的疫苗风险与破伤风、白喉、无细胞百日咳混合疫苗(Tdap)接受度显著相关(β = -0.57,p < 0.001)和流感疫苗接受度(β = -0.25,p < 0.001)。此外,aVHS分数较高的孕妇接受推荐产前疫苗的可能性较小。
尽管aVHS在衡量产前疫苗犹豫程度方面提供了可接受的测量方法,但一个衡量特定于怀孕的担忧的量表可能会为这个独特的人群提供更具针对性的测量。